Wilson’s病:一个潜在的可治疗的遗传性疾病*

doi:10.3969/j.issn.1672-5069.2020.02.002

实用肝脏病杂志 ›› 2020, Vol. 23 ›› Issue (2): 156-158.doi: 10.3969/j.issn.1672-5069.2020.02.002

Wilson’s病:一个潜在的可治疗的遗传性疾病^*

温博, 王炳元

110001 沈阳市中国医科大学附属第一医院老年消化科

收稿日期:2020-02-02 出版日期:2020-03-10 发布日期:2020-04-20
通讯作者: 王炳元, E-mail:wangby0908@163.com
作者简介:温博,女,33岁。主要从事慢性肝病诊治研究。E-mail:545877.happy@163.com
基金资助:
国家青年自然科学基金资助项目(编号:8170030364)

Wilson’s disease:A potentially treatable inherited disorder

Wen Bo, Wang Bingyuan

Department of Geriatric Gastroenterology,First Affiliated Hospital, China Medical University,Shenyang 110001,Liaoning Province, China

Received:2020-02-02 Online:2020-03-10 Published:2020-04-20

摘要/Abstract

关键词: Wilson’s病, 诊断, 治疗

Key words: Wilson’s disease, Diagnosis, Management

温博, 王炳元. Wilson’s病:一个潜在的可治疗的遗传性疾病^*[J]. 实用肝脏病杂志, 2020, 23(2): 156-158.

Wen Bo, Wang Bingyuan. Wilson’s disease:A potentially treatable inherited disorder[J]. Journal of Practical Hepatology, 2020, 23(2): 156-158.

[1] Poujois A, Woimant F. Challenges in the diagnosis of Wilson disease. Ann Transl Med, 2019, 7(Suppl 2):S67.
[2] Xie JJ, Wu ZY. Wilson's Disease in China. Neurosci Bull, 2017, 33(3):323-330.
[3] European Association for Study of Liver. EASL Clinical Practice Guidelines:Wilson's disease. J Hepatol, 2012, 56(3):671-685.
[4] Masełbas W, Członkowska A, Litwin T, et al. Persistence with treatment for Wilson disease: a retrospective study. BMC Neurol, 2019, 19(1):278.
[5] Zarina A, Tolmane I, Krumina Z, et al. Association of variants in the CP, ATOX1 and COMMD1 genes with Wilson disease symptoms in Latvia. Balkan J Med Genet, 2019, 22(2):37-42.
[6] Członkowska A, Litwin T, Dusek P, et al. Wilson disease. Nat Rev Dis Primers, 2018, 4(1):21.
[7] Mikol J, Vital C, Wassef M, et al. Extensive cortico-subcortical lesions in Wilson's disease: clinico-pathological study of two cases. Acta Neuropathol, 2005, 110(5):451-458.
[8] Li LY, Zhu XQ, Tao WW, et al. Acute onset neurological symptoms in Wilson disease after traumatic, surgical or emotional events: A cross-sectional study. Medicine (Baltimore), 2019, 98(26):e15917.
[9] Saroli Palumbo C, Schilsky ML. Clinical practice guidelines in Wilson disease. Ann Transl Med, 2019, 7(Suppl 2):S65.
[10] Bobbio E, Forsgard N, Oldfors A, et al. Cardiac arrest in Wilson's disease after curative liver transplantation: a life-threatening complication of myocardial copper excess? ESC Heart Fail, 2019, 6(1):228-231.
[11] Hedera P. Wilson's disease: A master of disguise. Parkinsonism Relat Disord, 2019, 59:140-145.
[12] Medici V, Weiss KH. Genetic and environmental modifiers of Wilson disease. Handb Clin Neurol, 2017, 142:35-41.
[13] Socha P, Janczyk W, Dhawan A, et al. Wilson's disease in children: A position paper by the Hepatology Committee of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr, 2018, 66(2):334-344.
[14] Członkowska A, Litwin T, Dziez·yc K, et al. Characteristics of a newly diagnosed Polish cohort of patients with neurological manifestations of Wilson disease evaluated with the unified Wilson's disease rating scale. BMC Neurol, 2018, 18(1):34.
[15] Yu XE, Pan M, Han YZ,et al. The study of Wilson disease in pregnancy management. BMC Pregnancy Childbirth, 2019, 19(1):522.
[16] Poujois A, Woimant F. Wilson's disease: A 2017 update. Clin Res Hepatol Gastroenterol, 2018, 42(6):512-520.
[17] Low QJ, Siaw C, Lee RA, et al. Kayser-Fleischer fings & Wilson's disease.QJM, 2020, 9. pii: hcaa005.
[18] Valentino PL, Roberts EA, Beer S, et al. Management of Wilson disease diagnosed in infancy: An appraisal of available experience to generate discussion. J Pediatr Gastroenterol Nutr, 2020[ahead of print] .
[19] Poon KS, Teo ZH, Yap JH, et al. Challenges in molecular diagnosis of Wilson disease: viewpoint from the clinical laboratory. J Clin Pathol, 2019, 3. pii: jclinpath-2019-206054.
[20] Roberts EA, Schilsky ML, American Association for Study of Liver Diseases (AASLD). Diagnosis and treatment of Wilson disease: an update. Hepatology, 2008, 47(6):2089-2111.
[21] Ferenci P, Caca K, Loudianos G, et al. Diagnosis and phenotypic classification of Wilson disease. Liver Int, 2003, 23(3):139-142.
[22] Hermann W. Classification and differential diagnosis of Wilson's disease. Ann Transl Med, 2019, 7(Suppl 2):S63.
[23] Xu MB, Rong PQ, Jin TY, et al. Chinese herbal medicine for Wilson's disease: A systematic review and Meta-analysis. Front harmacol, 2019, 10:277.
[24] Pfeiffenberger J, Beinhardt S, Gotthardt DN, et al. Pregnancy in Wilson's disease: Management and outcome. Hepatology, 2018, 67(4):1261-1269.

Wilson’s病:一个潜在的可治疗的遗传性疾病^*

Wilson’s disease:A potentially treatable inherited disorder

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	王儒阳, 吴思嘉, 佟静, 李异玲. Wilson’s病影像学特征^*[J]. 实用肝脏病杂志, 2020, 23(2): 159-162.
[2]	周翠梅, 胡立芬, 李家斌, 储雪琴, 郜玉峰. 思维导图在慢性乙型肝炎患者管理中应用价值研究^*[J]. 实用肝脏病杂志, 2020, 23(2): 187-190.
[3]	张晓伟, 钟蕊. 索磷布韦和维帕他韦联合利巴韦林治疗基因2、3型慢性丙型肝炎患者近期疗效和耐受性观察^*[J]. 实用肝脏病杂志, 2020, 23(2): 191-194.
[4]	贾晨, 张涛, 王浩, 戚凤君. 利拉鲁肽治疗非酒精性脂肪性肝病合并2型糖尿病患者血脂、血管内皮功能和肝纤维化指标的变化^*[J]. 实用肝脏病杂志, 2020, 23(2): 203-206.
[5]	曾震军, 李墨航. 血清学指标和脂肪肝指数诊断非酒精性脂肪性肝病价值分析^*[J]. 实用肝脏病杂志, 2020, 23(2): 211-214.
[6]	叶细容, 吕志洪, 解育新, 江峰. 声辐射力脉冲成像超声定量检测评估儿童脂肪肝应用价值探讨^*[J]. 实用肝脏病杂志, 2020, 23(2): 223-226.
[7]	王红学, 朱清静, 张玉娟, 毛重山. 异甘草酸镁联合乙酰半胱氨酸治疗药物性肝损伤患者血清氧化应激指标的改变^*[J]. 实用肝脏病杂志, 2020, 23(2): 227-230.
[8]	张玉玲, 周瑾, 董宏伟. 超声点定量弹性成像技术对AIH和PBC患者肝纤维化诊断价值分析^*[J]. 实用肝脏病杂志, 2020, 23(2): 231-235.
[9]	李永超, 任红军, 刘磊, 张松. 双重血浆吸附联合血浆置换治疗慢加急性乙型肝炎肝衰竭患者临床疗效研究^*[J]. 实用肝脏病杂志, 2020, 23(2): 236-239.
[10]	贾娇, 王芳, 张波, 武琼. 熊去氧胆酸联合骨化三醇治疗原发性胆汁性肝硬化患者疗效和外周血T淋巴细胞亚群的变化^*[J]. 实用肝脏病杂志, 2020, 23(2): 240-243.
[11]	张惠勇, 吴秀欣, 徐成润. 特利加压素联合前列地尔辅助腹水超滤浓缩回输治疗肝硬化并发难治性腹水患者疗效分析^*[J]. 实用肝脏病杂志, 2020, 23(2): 244-247.
[12]	范建高. 不忘初心,砥励前行[J]. 实用肝脏病杂志, 2020, 23(1): 1-1.
[13]	陈从新, 王莉苹. 应用皮质激素治疗肝衰竭存在什么争议？[J]. 实用肝脏病杂志, 2020, 23(1): 2-3.
[14]	范文瀚, 罗怡平, 李成忠. 糖皮质激素应用于肝衰竭治疗机制及其临床时机的把握[J]. 实用肝脏病杂志, 2020, 23(1): 7-9.
[15]	纪宇欣, 李树臣. 应用糖皮质激素治疗肝衰竭临床疗效研究进展[J]. 实用肝脏病杂志, 2020, 23(1): 10-13.